STEERING COMMITTEE

Steering Committee

Illumina, Inc.

Invitae Corporation

Laboratory Corporation of America^® Holdings (LabCorp^®)

Myriad Women’s Health, Inc.

Natera, Inc.

The Conafay Group

OUR MISSION

The Coalition for Access to Prenatal Screening (CAPS) is a collaborative alliance of five leading genetic testing companies in the U.S. that seeks to improve access to state-of-the-art prenatal screening using cell-free DNA (cfDNA)-based noninvasive prenatal screening (NIPS) that is easily accessible to all pregnant women who choose to pursue aneuploidy screening, regardless of their risk factors, income, age or geographic location.

Learn More »

LINKS AND RESOURCES

STATEMENTS
PUBLICATIONS

CAPS Announces Clinical Advisory Board »

Improve Access to cfDNA-based Non-Invasive Prenatal Screening PDF »

CAPS Press Release PDF »

GET IN TOUCH

info@capsprenatal.com
Follow us @CAPSPrenatal

Tweets by CAPSPrenatal

Steering Committee

Illumina, Inc. Invitae Corporation Laboratory Corporation of America® Holdings (LabCorp®) Myriad Women’s Health, Inc. Natera, Inc. The Conafay Group

Illumina, Inc.

Invitae Corporation

Laboratory Corporation of America^® Holdings (LabCorp^®)

Myriad Women’s Health, Inc.

Natera, Inc.

The Conafay Group